Can-Fite Biopharma Ltd ADR (CANF)

Nov 11, 2024

Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial - GlobeNewswire Inc.

Nov 11, 2024

Nov 04, 2024

Can-Fite secures Australian patent for obesity treatment - Investing.com

Nov 04, 2024

Oct 18, 2024

Can-Fite's partner Vetbiolix secures $325M deal for dog arthritis drug - Investing.com India

Oct 18, 2024

Sep 25, 2024

Ratios in Focus: Analyzing Can-Fite Biopharma Ltd ADR (CANF)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 25, 2024

Sep 24, 2024

What is CANF’s price-to-sales ratio telling us about the company’s value? - US Post News

Sep 24, 2024

Sep 02, 2024

Taking on analysts’ expectations and winning: Can-Fite Biopharma Ltd ADR (CANF) - SETE News

Sep 02, 2024

Sep 02, 2024

Analytical Lens: Exploring Can-Fite Biopharma Ltd ADR (CANF)’s Financial Story Through Ratios - The Dwinnex

Sep 02, 2024

Sep 02, 2024

CANF (Can-Fite Biopharma Ltd ADR) has impressive results - US Post News

Sep 02, 2024

Aug 26, 2024

List of Israeli Stocks Traded on the NYSE Worth Considering - The Times of Israel

Aug 26, 2024

Aug 23, 2024

Wearable Devices Ltd. sets annual meeting for September 26 - Investing.com

Aug 23, 2024

Jul 17, 2024

Can-Fite BioPharma shares upgraded by EF Hutton to Buy on pipeline drugs - Investing.com

Jul 17, 2024

Jun 28, 2024

GitLab stock maintains buy rating on new release By Investing.com - Investing.com

Jun 28, 2024

Jun 28, 2024

Pacira's (PCRX) Q3 Earnings Miss Estimates, Revenues Beat - Yahoo New Zealand News

Jun 28, 2024

Jun 28, 2024

Canine arthritis treatment shows promise in clinical study - Investing.com India

Jun 28, 2024

Jun 25, 2024

Can-Fite reveals adiponectin role in cancer treatment By Investing.com - Investing.com

Jun 25, 2024

Jun 19, 2024

Was Can-Fite Biopharma Ltd ADR (CANF)'s session last reading good? – US Post News - US Post News

Jun 19, 2024

Jun 05, 2024

Can-Fite's Namodenoson gains FDA Fast Track for liver cancer - Investing.com India

Jun 05, 2024

Jun 05, 2024

Can-Fite's Namodenoson gains FDA Fast Track for liver cancer By Investing.com - Investing.com

Jun 05, 2024

Apr 15, 2024

Can-Fite's Namodenoson advances in Phase III liver cancer trial By Investing.com - Investing.com

Apr 15, 2024

Apr 03, 2024

Can-Fite BioPharma seeks FDA nod for NASH drug trial By Investing.com - Investing.com

Apr 03, 2024

Jan 05, 2024

ANVS Stock Quote Price and Forecast - CNN

Jan 05, 2024

Nov 21, 2023

symbol__ Stock Quote Price and Forecast - CNN

Nov 21, 2023

Jul 12, 2023

Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight - PR Newswire

Jul 12, 2023

Dec 30, 2022

Can-Fite Announces ADS Ratio Change - Business Wire

Dec 30, 2022

Nov 10, 2022

Catalyst's (CPRX) Q3 Earnings & Revenues Surpass Estimates - Nasdaq

Nov 10, 2022

Oct 19, 2022

Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici

Oct 19, 2022

Mar 16, 2021

Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma - Business Wire

Mar 16, 2021

Feb 25, 2021

Best Penny Stocks Today | Penny Stocks to Buy Now -TipRanksTipRanks.com - TipRanks

Feb 25, 2021

Oct 15, 2020

The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Trea - Benzinga

Oct 15, 2020

Sep 16, 2020

Can-Fite BioPharma (CANF) Stock Price, News & Analysis - MarketBeat

Sep 16, 2020

Mar 03, 2020

The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And Mo - Benzinga

Mar 03, 2020

Jan 09, 2020

32 Stocks Moving In Thursday's Mid-Day SessionAEterna Zentaris (NASDAQ:AEZS), ADMA Biologics (NASDAQ:A - Benzinga

Jan 09, 2020

Aug 24, 2019

10 Biopharmaceutical Companies Trying To Cure Cancer - Yahoo Finance

Aug 24, 2019

Aug 08, 2019

The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax OfferingiShares B - Benzinga

Aug 08, 2019

May 24, 2019

Secondary Offerings Put A Pause On May's MomentumMynd.ai (AMEX:MYND), Can Fite Biofarma (AMEX:CANF) - Benzinga

May 24, 2019

Feb 05, 2018

28 Stocks Moving In Monday's Pre-Market Session - Benzinga

Feb 05, 2018

Apr 25, 2017

20 Biggest Mid-Day Gainers For TuesdayAlcoa (NYSE:AA), Biogen (NASDAQ:BIIB) - Benzinga

Apr 25, 2017

Aug 02, 2016

Can-Fite's Rheumatoid Arthritis Drug Faces Off With Methotrexate In Phase III Trial For $40 Billion Market (NYSE:CANF) - Seeking Alpha

Aug 02, 2016

Oct 05, 2015

Propanc Health Group Corp : This Company Could Be the Next CETX or CANF - Marketscreener.com

Oct 05, 2015

Sep 17, 2015

Morning Market GainersCan Fite Biofarma (AMEX:CANF) - Benzinga

Sep 17, 2015

Oct 04, 2012

Can-Fite BioPharma Begins Trading in U.S. through Launch of ADRs - CNBC

Oct 04, 2012